Reply to the letter to the editor: [Comment on "The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention]
- PMID: 33103222
- DOI: 10.1007/s10554-020-01905-6
Reply to the letter to the editor: [Comment on "The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention]
Abstract
We have read with a great pleasure the letter of Dr. Cure et al. to the editor about our recent study which showed an association between atherogenic index of plasma (AIP) and no-reflow in patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Dr Cure raises concerns about the miscalculation of AIP value that suggested choosing 'mmol/l' in equation instead of 'mg/dl'. As the AIP is the logarithmic transformation of triglyceride/high density lipoprotein; 'mmol/l' and an alternatively 'mg/dl' units can be used in the equation to calculate AIP values. Cure et al. also argue that our patients' lipoprotein levels were lower than expected. However, in a population based study and in several studies which were held in Turkey, the mean values of lipoprotein levels in Turkish population were nearly similar with our study population findings. We thank the authors' letter for pointing out these issues which we hope to have addressed.
Keywords: Atherogenic index of plasma; No-reflow; Percutaneous coronary intervention; ST-segment elevation myocardial infarction.
Comment on
-
Comment on "The relationship between atherogenic index of plasma and no‑reflow in patients with acute ST‑segment elevation myocardial infarction who underwent primary percutaneous coronary intervention".Int J Cardiovasc Imaging. 2020 May;36(5):797-798. doi: 10.1007/s10554-020-01781-0. Epub 2020 Feb 18. Int J Cardiovasc Imaging. 2020. PMID: 32067176
References
-
- Cure E, Cumhur CM (2020) Comment on "The relationship between atherogenic index of plasma and noreflow in patients with acute STsegment elevation myocardial infarction who underwent primary percutaneous coronary intervention". Int J Cardiovasc Imaging 36(5):797–798 - DOI
-
- Suleymanoglu M, Rencuzogullari I, Karabag Y, Cagdas M, Yesin M, Gumusdag A et al (2020) The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Int J Cardiovasc Imaging 9(10):019–01766
-
- Dobiasova M, Frohlich J (2001) The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 34(7):583–588 - DOI
-
- Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V et al (1995) Turkish heart study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 36(4):839–859 - DOI
-
- Güntekin Ü, Tosun V, Kilinç AY, Saydam G, Korucuk N, Bozdemir MN (2018) ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals: a retrospective analysis of patients presenting with first acute coronary syndromes. Medicine 97(39):e12225 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
